Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Melanoma 13Lymphoma 11Lymphoma, Follicular 10Breast Neoplasms 10Multiple Myeloma 9Prostatic Neoplasms 8Neoplasms, Plasma Cell 8Leukemia, Myeloid, Acute 7Colonic Neoplasms 7Pancreatic Neoplasms 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 5Lymphoma, Non-Hodgkin 5Leukemia 5Kidney Neoplasms 5Small Cell Lung Carcinoma 4Rectal Neoplasms 4Ovarian Neoplasms 4Neoplasms 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Lung Neoplasms 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4HIV Infections 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Acquired Immunodeficiency Syndrome 4Testicular Neoplasms 3

Interventions

fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4Carboplatin 4veliparib 2tipifarnib 2Topotecan 2Prednisone 2Imatinib Mesylate 2Filgrastim 2Etoposide 2Decitabine 2Cytarabine 2Cyclosporine 2tanespimycin 1sargramostim 1romidepsin 1iadademstat 1decitabine and cedazuridine drug combination 1Vorinostat 1Vincristine 1Thiotepa 1Tacrolimus 1Sunitinib 1Specimen Handling 1Rituximab 1Radiotherapy 1Pharmacogenomic Testing 1Mycophenolic Acid 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Thrombocythemia, Essential × sargramostim × Clear all
NCT00004036 2013-12-19

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡